ReviewCancers2020

Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current Literature.

Eirini Thanopoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.